March 30, 2023 02:28 PM EDT

Massachusetts judge dismisses lawsuit against Biogen over failed launch of Alzheimer's drug Aduhelm

Katherine Lewin

News Reporter

A Massachusetts federal judge on Wednesday dismissed a class action lawsuit filed by investors against Biogen and several of its current and former executives over …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER

Massachusetts judge dismisses lawsuit against Biogen over failed launch of Alzheimer's drug Aduhelm

Katherine Lewin

News Reporter

Sign up to read this article for free.

Sr. Manager/Associate Director, Document Control

Viridian Therapeutics

Waltham, MA, USA

BridgeBio shares promising results in trial of Canavan disease gene therapy

CRISPR therapy reduces swelling attacks by 81% in Intellia follow-up study

Facing lost rebates, MGM Resorts to stop covering GLP-1 weight loss shots

Exclusive: University of Toronto spinout raises $53.5M to create new obesity drugs with AI

Icon's quarterly earnings hit by biotech and pharma pullback

IDEAYA Biosciences: Targeting unmet market needs with precision oncology

Mass­a­chu­setts judge dis­miss­es law­suit against Bio­gen over failed launch of Alzheimer's drug Aduhelm

News Reporter

Sign up to read this article for free.

Viridian Therapeutics

Waltham, MA, USA

Massachusetts judge dismisses lawsuit against Biogen over failed launch of Alzheimer's drug Aduhelm